ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
5 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: December 2019 Quarterly Report
|
|
TTE
|
22 |
17K |
4 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
22
|
17K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
7 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C
|
|
TTE
|
26 |
13K |
4 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
26
|
13K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
5 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
135
|
88K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: December 2019 Quarterly Report
|
|
TTE
|
22 |
17K |
5 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
22
|
17K
|
5
|
|
ASX - By Stock
|
BUD |
Re:
Charts - BUD
|
|
TTE
|
424 |
189K |
0 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
424
|
189K
|
0
|
|
ASX - By Stock
|
BUD |
Re:
Charts - BUD
|
|
TTE
|
424 |
189K |
3 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
424
|
189K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
2 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
135
|
88K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
1 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
135
|
88K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
0 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
135
|
88K
|
0
|
|
ASX - By Stock
|
IXC |
Why IXC is a Strong BUY awaiting Phase 2 results in March 2020
|
|
TTE
|
46 |
18K |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
46
|
18K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Invex - A
|
|
TTE
|
4 |
2.0K |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
4
|
2.0K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Invex - A
|
|
TTE
|
4 |
2.0K |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
4
|
2.0K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Invex - A
|
|
TTE
|
4 |
2.0K |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
4
|
2.0K
|
0
|
|
ASX - By Stock
|
BUD |
Re:
Charts - BUD
|
|
TTE
|
424 |
189K |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
424
|
189K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
5 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
7 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
TTE
|
29K |
13M |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
29K
|
13M
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Options issue
|
|
TTE
|
6 |
2.0K |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
6
|
2.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
5 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
135
|
88K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
3 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
135
|
88K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Director Changes and First Innovation and Research Centre
|
|
TTE
|
42 |
20K |
5 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
42
|
20K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Director Changes and First Innovation and Research Centre
|
|
TTE
|
42 |
20K |
4 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
42
|
20K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
135
|
88K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
135
|
88K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
5 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
135
|
88K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
135
|
88K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
8 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
135
|
88K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
TTE
|
135 |
88K |
14 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
135
|
88K
|
14
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 3B Convertible Note Conversion
|
|
TTE
|
9 |
7.3K |
0 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
9
|
7.3K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
3 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
5 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|